DNA
ISLAMABAD: Federal Capital, Islamabad (Pakistan) – Incumbent President (NCP) Chief Daniel Ilesanmi Imuzie expressed his personal views after a visit to Max Pharmaceuticals Rawat Industrial Estate, Rawalpindi. He said that the pharmaceutical imports from Pakistan to Nigeria have crossed more than double to US$1.3 trillion during the year 2020.
He added that although there are currently over 130 pharmaceutical companies in Nigeria but Pakistan Pharmaceutical Industry is expected to penetrate through steady growth into the Nigerian Pharma Industry.
Secretary General (NCP) Engr. Michael Lance Okafor highlighted that Nigeria Pakistan Pharma products have very bright future as Nigeria and Pakistan have similar disease burden with a significant proportion of deaths attributable to communicable diseases with Malaria, Diarrhea and Dysentery being common amongst Pakistanis and Nigerians.
He added that there have been many laudable efforts by NAFDAC – the main regulatory body in Nigeria – to standardize the pharmaceutical industry despite the fact that Nigeria has critically low levels of human and infrastructure resources for health care.
